RxDoctor Payments Data

Marci Johnson

Family · Douglas, GANPI 1619521820

Payments from drug & device makers

$2,719in general payments, 2019–2025

Across 147 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$669
  • Novartis$393
  • E.r. Squibb & Sons, L.L.C.$383
  • AstraZeneca$229
  • Amgen$194
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$133
  • plus $717 from 14 others

What the payments were for

  • Food & beverage$2,70599%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,719 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$47,854
Medicare patients
295
Services billed
679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban394$281,334
Repatha SureclickEvolocumab295$169,845
EntrestoSacubitril/Valsartan185$153,556
BrilintaTicagrelor170$94,282
Praluent PenAlirocumab77$42,364
FarxigaDapagliflozin Propanediol47$32,430
XareltoRivaroxaban28$22,743
Ranolazine ErRanolazine129$5,941
Rosuvastatin Calcium566$5,656
Isosorbide Mononitrate ErIsosorbide Mononitrate314$3,351
Ezetimibe196$2,921
Metoprolol Succinate353$2,882
ClopidogrelClopidogrel Bisulfate298$2,629
Carvedilol400$2,624
Atorvastatin Calcium292$2,390

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$113$281,334394 claims
NovartisEntresto$393$153,556185 claims
AstraZenecaBrilinta, Farxiga$229$126,713217 claims
Johnson & JohnsonXarelto$50$22,74328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.

Other family in Douglas

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →